BioMarin to Participate in Three Upcoming Virtual Investor Conferences

– Barclays Gene Editing & Gene Therapy Summit on November 16 at 1:00pm ET

– Stifel 2020 Virtual Healthcare Conference on November 17 at 2:00pm ET

– Jefferies Virtual London Healthcare Conference on November 17 at 1:10pm ET/6:10pm GMT

PR Newswire

SAN RAFAEL, Calif., Nov. 12, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company’s portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. 

For additional information, please visit Information on BioMarin’s website is not incorporated by reference into this press release.




Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451


Cision View original content to download multimedia:

SOURCE BioMarin Pharmaceutical Inc.